HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) today announced that the Supreme Court of the State of Israel (the “Supreme Court”) has ruled that Sun Pharmaceutical Industries Ltd. (“Sun”) may not exercise a warrant to purchase additional Taro shares while a previously ordered temporary injunction remains in effect. In a separate case, the Tel Aviv District Court recently struck out almost all of Sun’s allegations against Taro and its Board of Directors in a case brought by Sun regarding Taro’s financial statements.
